Insulet OmniPod Recall Tagged As Class I
This article was originally published in The Gray Sheet
FDA designated a recall of Insulet’s OmniPod insulin management system as class I based on a higher than expected rate of failure in some lots. In some cases, cannulas either completely retracted or failed to fully deploy; in others, pods stopped pumping insulin and sounded an alarm.
Register for our free email digests: